| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.92% | -71.34% | 384.21% | 101/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 0.19% | -93.21% | -57.78% | 104/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.45% | -71.34% | -85.67% | 100/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.14% | -57.39% | -2.18% | 75/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 3.21% | -48.89% | 14.64% | 82/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.8% | -41.79% | 78.34% | 66/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.57% | -9.77% | -78.7% | 72/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 7.37% | 38.79% | 17.36% | 43/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 6.28% | 77.9% | 30.56% | 53/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.81% | 113.78% | 176.44% | 44/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.74% | 39.2% | -67.23% | 65/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.31% | -60.67% | 50.42% | 72/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.53% | -69.91% | 56.89% | 77/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.25% | -72.99% | 80% | 80/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.25% | 2% | -90.74% | 82/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 13.5% | -52.76% | 15.09% | 27/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 11.73% | 2% | 40.82% | 25/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.33% | -53.28% | -70.85% | 22/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 28.58% | 0.49% | 60.29% | 6/158 | 3.66% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | 17.83% | 2% | -37.31% | 4/158 | 4.23% | 哈三联 | 27.17% | 行业排名> |
| 2019-12-31 | 28.44% | 57.48% | 57.48% | 6/158 | 2.57% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-12-31 | 18.06% | 500% | 500% | 22/158 | 7.17% | 河化股份 | 45.32% | 行业排名> |
| 2017-12-31 | 3.01% | 2% | 2% | 101/158 | 9.68% | 汇宇制药 | 31.9% | 行业排名> |

微信公众号
证券之星APP


